A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
University Hospital is unique in the region for many services, including central Ohio’s only adult solid organ transplant program and a groundbreaking Center for Neuromodulation, which pioneers procedures such as deep brain stimulation that can dramatically improve the lives of people with specific neurological and psychiatric symptoms.
Columbus, Ohio Clinical Trial Location
Ohio State University
410 W 10th Ave,
Columbus, OH 43210